Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes - Galtier, Jean; Alric, Camille; Bérard, Emilie; Leguay, Thibaut; Tavitian, Suzanne; Bidet, Audrey; Delabesse, Eric; Rieu, Jean Baptiste; Vial, Jean-Philippe; Vergez, François; Lechevalier, Nicolas; Luquet, Isabelle; et al. (Blood cancer journal (New York), 2021)
Keywords: 631/67/1990/283/1897; 692/699/1541/1990/283/1897; Aged; Anthracyclines - administration & dosage; Antineoplastic Combined Chemotherapy Protocols - administration & dosage; Biomedical and Life Sciences; Biomedicine; Cancer; Cancer Research; Correspondence; Cytarabine - administration & dosage; Female; Hematology; Humans; Leukemia, Myeloid, Acute - drug therapy; Life Sciences; Male; Middle Aged; Oncology; Registries; Remission Induction